![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 46, 38247-38258, November 18, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Program in Cardiovascular Transcriptional Biology, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115
Activation of macrophages is important in chronic inflammatory disease states such as atherosclerosis. Proinflammatory cytokines such as interferon-
(IFN-
), lipopolysaccharide (LPS), or tumor necrosis factor-
can promote macrophage activation. Conversely, anti-inflammatory factors such as transforming growth factor-
1 (TGF-
1) can decrease proinflammatory activation. The molecular mediators regulating the balance of these opposing effectors remain incompletely understood. Herein, we identify Kruppel-like factor 4 (KLF4) as being markedly induced in response to IFN-
, LPS, or tumor necrosis factor-
and decreased by TGF-
1 in macrophages. Overexpression of KLF4 in J774a macrophages induced the macrophage activation marker inducible nitric-oxide synthase and inhibited the TGF-
1 and Smad3 target gene plasminogen activator inhibitor-1 (PAI-1). Conversely, KLF4 knockdown markedly attenuated the ability of IFN-
, LPS, or IFN-
plus LPS to induce the iNOS promoter, whereas it augmented macrophage responsiveness to TGF-
1 and Smad3 signaling. The KLF4 induction of the iNOS promoter is mediated by two KLF DNA-binding sites at 95 and 212 bp, and mutation of these sites diminished induction by IFN-
and LPS. We further provide evidence that KLF4 interacts with the NF-
B family member p65 (RelA) to cooperatively induce the iNOS promoter. In contrast, KLF4 inhibited the TGF-
1/Smad3 induction of the PAI-1 promoter independent of KLF4 DNA binding through a novel antagonistic competition with Smad3 for the C terminus of the coactivator p300/CBP. These findings support an important role for KLF4 as a regulator of key signaling pathways that control macrophage activation.
Received for publication, August 25, 2005 , and in revised form, September 9, 2005.
* This work was supported by National Institutes of Health Grant HL-67755 (to M. W. F.), HL-69477 (to M. K. J.), HL-72952 (to M. K. J.), HL-75427 (to M. K. J.), and HL-76754 (to M. K. J.), American Heart Association Awards 0355691T (to M. W. F.) and 0250030N (to M. K. J.), and American Diabetes Association Award 102-JF-40 (to M. K. J.). This work was also supported by a Carl J. and Ruth Shapiro Scholar Award (to M. W. F.) and a Lerner Junior Faculty Scholar Award (to M. W. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA 02115. Tel.: 617-732-7820; Fax: 617-732-5132; E-mail: mfeinberg{at}rics.bwh.harvard.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. V. Autieri Kruppel-Like Factor 4: Transcriptional Regulator of Proliferation, or Inflammation, or Differentiation, or All Three? Circ. Res., June 20, 2008; 102(12): 1455 - 1457. [Full Text] [PDF] |
||||
![]() |
T. Yoshida, K. H. Kaestner, and G. K. Owens Conditional Deletion of Kruppel-Like Factor 4 Delays Downregulation of Smooth Muscle Cell Differentiation Markers but Accelerates Neointimal Formation Following Vascular Injury Circ. Res., June 20, 2008; 102(12): 1548 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Gordon, S. V. Outram, M. Keramatipour, C. A. Goddard, W. H. Colledge, J. C. Metcalfe, A. L. Hager-Theodorides, T. Crompton, and P. R. Kemp Splenomegaly and Modified Erythropoiesis in KLF13-/- Mice J. Biol. Chem., May 2, 2008; 283(18): 11897 - 11904. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Alder, R. W. Georgantas III, R. L. Hildreth, I. M. Kaplan, S. Morisot, X. Yu, M. McDevitt, and C. I. Civin Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo J. Immunol., April 15, 2008; 180(8): 5645 - 5652. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhou and S. Amar Identification of Signaling Pathways in Macrophage Exposed to Porphyromonas gingivalis or to Its Purified Cell Wall Components J. Immunol., December 1, 2007; 179(11): 7777 - 7790. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hartiala, J. Hytonen, J. Pelkonen, K. Kimppa, A. West, M. A. Penttinen, J. Suhonen, R. Lahesmaa, and M. K. Viljanen Transcriptional response of human dendritic cells to Borrelia garinii--defective CD38 and CCR7 expression detected J. Leukoc. Biol., July 1, 2007; 82(1): 33 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hamik, Z. Lin, A. Kumar, M. Balcells, S. Sinha, J. Katz, M. W. Feinberg, R. E. Gerszten, E. R. Edelman, and M. K. Jain Kruppel-like Factor 4 Regulates Endothelial Inflammation J. Biol. Chem., May 4, 2007; 282(18): 13769 - 13779. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Methe, M. Balcells, M. del Carmen Alegret, M. Santacana, B. Molins, A. Hamik, M. K. Jain, and E. R. Edelman Vascular bed origin dictates flow pattern regulation of endothelial adhesion molecule expression Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2167 - H2175. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zeng, S. Zhuang, J. Gloddek, C.-C. Tseng, G. R. Boss, and R. B. Pilz Regulation of cGMP-dependent Protein Kinase Expression by Rho and Kruppel-like Transcription Factor-4 J. Biol. Chem., June 23, 2006; 281(25): 16951 - 16961. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Patino, J.-G. Kang, S. Matoba, O. Y. Mian, B. R. Gochuico, and P. M. Hwang Atherosclerotic Plaque Macrophage Transcriptional Regulators Are Expressed in Blood and Modulated by Tristetraprolin Circ. Res., May 26, 2006; 98(10): 1282 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chanchevalap, M. O. Nandan, B. B. McConnell, L. Charrier, D. Merlin, J. P. Katz, and V. W. Yang Kruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells Nucleic Acids Res., February 25, 2006; 34(4): 1216 - 1223. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |